Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Secondary Antibodies
  5. Mouse Secondary Antibodies
  6. NB002827

Mouse anti-Human IgM Heavy Chain Secondary Antibody (47.2.E9), Novus Biologicals™
SDP

Catalog No. NB002827 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB002827 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB002827 Supplier Novus Biologicals Supplier No. NBP268319200UG
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

IgM Heavy Chain Monoclonal specifically detects IgM Heavy Chain in Human samples. It is validated for ELISA.

Specifications

Antigen IgM
Applications ELISA
Classification Monoclonal
Clone 47.2.E9
Concentration 1 mg/mL
Conjugate Unconjugated
Dilution ELISA 1:5000 - 1:10000
Formulation PBS
Gene Alias AGM1, DKFZp686I15196, DKFZp686I15212, FLJ00385, immunoglobulin heavy constant mu, MGC104996, MGC52291, MU, VH
Gene Symbols IGHM
Host Species Mouse
Immunogen Purified human IgM
Quantity 200 μg
Research Discipline B Cell Development and Differentiation Markers, Immunology
Gene ID (Entrez) 3507
Test Specificity Mouse anti Human IgM antibody, clone 47.2.E9, reacts with human IgM and recognizes the Mu chain
Target Species Human
Content And Storage Store at 4°C.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.